Neutralising antibodies after COVID-19 vaccination in UK haemodialysis patients

Neutralising antibodies after COVID-19 vaccination in UK haemodialysis patients

Bibliografske podrobnosti
Main Authors:	Carr, EJ, Wu, M, Harvey, R, Wall, EC, Kelly, G, Hussain, S, Howell, M, Kassiotis, G, Swanton, C, Gandhi, S, Bauer, DL, Issa, FG, Billany, RE, Graham-Brown, MP, Beckett, J, Bull, K, Shankar, S, Henderson, S, Motallebzadeh, R, Salama, AD, Harper, L, Mark, PB, McAdoo, S, Willicombe, M, Beale, R
Drugi avtorji:	Haemodialysis COVID-19 consortium
Format:	Journal article
Jezik:	English
Izdano:	Elsevier 2021

Podobne knjige/članki

Distinct Neutralising and Complement-Fixing Antibody Responses Can Be Induced to the Same Antigen in Haemodialysis Patients After Immunisation with Different Vaccine Platforms
od: Nadezhda Wall, et al.
Izdano: (2024-12-01)

What Do Reference Librarians Do Now?
od: Monty L. McAdoo
Izdano: (2022-09-01)

Toward a more comprehensive modeling of sequential lineups
od: David Kellen, et al.
Izdano: (2022-07-01)

Fundamentals of library instruction /
od: 527542 McAdoo, Monty L.
Izdano: (2012)

Mechanisms of rhinovirus neutralisation by antibodies
od: Touabi, Lila, et al.
Izdano: (2021)

Mechanisms of Rhinovirus Neutralisation by Antibodies
od: Lila Touabi, et al.
Izdano: (2021-02-01)

Neutralising Neurophobia
od: Greg Lamb
Izdano: (2018-03-01)

Structural determinants of Bunyavirus entry and neutralisation
od: Stass, R
Izdano: (2019)

P06 OFATUMUMAB FOR B CELL DEPLETION THERAPY IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS WHO ARE INTOLERANT OF RITUXIMAB
od: S. McAdoo, et al.
Izdano: (2016-11-01)

Comparison of immunogenicity and clinical effectiveness between BNT162b2 and ChAdOx1 SARS-CoV-2 vaccines in people with end-stage kidney disease receiving haemodialysis: A prospective, observational cohort study
od: Paul Martin, et al.
Izdano: (2022-10-01)

Primary IgA nephropathy: current challenges and future prospects
od: Penfold RS, et al.
Izdano: (2018-04-01)

Cross-Neutralisation of Novel Bombali Virus by Ebola Virus Antibodies and Convalescent Plasma Using an Optimised Pseudotype-Based Neutralisation Assay
od: Emma M. Bentley, et al.
Izdano: (2021-08-01)

Neutralisation and transport of negative ion beams: physics and diagnostics
od: G Serianni, et al.
Izdano: (2017-01-01)

Editorial: The kidney in auto-immune and auto-inflammatory processes: Definitions, mechanisms, and biomarkers
od: Augusto Vaglio, et al.
Izdano: (2023-01-01)

Neutralising and Non-neutralising Antibodies to SARS-CoV-2: Role during Infection and in the Evolution of Antigenic structure
od: S. K. Pylaeva, et al.
Izdano: (2025-01-01)

Development of an Integrated Approach to Neutralisation of Oil-Slime
od: E.M. Sulman, et al.
Izdano: (2014-08-01)

Can deliberation neutralise power?
od: Bagg, S
Izdano: (2015)

SARS-CoV-2 Antibody Point-of-Care Testing in Dialysis and Kidney Transplant Patients With COVID-19Plain-Language Summary
od: Maria Prendecki, et al.
Izdano: (2021-01-01)

E kolo ana nō ke ēwe i ke ēwe: Our genealogy of building Pōpolo & Kānaka ʻŌiwi sisterhood through the Sister Circle at Mānoa
od: LaJoya Reed Shelly, et al.
Izdano: (2024-05-01)

Severe COVID‐19 is associated with endothelial activation and abnormal glycosylation of von Willebrand factor in patients undergoing hemodialysis
od: Golzar Mobayen, et al.
Izdano: (2021-08-01)

Evaluation of a Pseudotyped Virus Neutralisation Test for the Measurement of Equine Influenza Virus-Neutralising Antibody Responses Induced by Vaccination and Infection
od: Rebecca Kinsley, et al.
Izdano: (2020-08-01)

Markedness Neutralisation and the Unity of Opposites in Heraclitus
od: Keith Begley
Izdano: (2024-09-01)

Demilitarisation and neutralisation in the context of European security
od: Åsa Gustafsson
Izdano: (2022-03-01)

Neutralising ordnance with non-extending elements
od: Alexander I. Golodyaev
Izdano: (2014-04-01)

Neutralising antibodies against ricin toxin.
od: Julie Prigent, et al.
Izdano: (2011-01-01)

Åland Demilitarisation and Neutralisation – International Lessons
od: Robert Rydberg
Izdano: (2022-03-01)

Routes to Improve Arteriovenous Fistula Formation for Haemodialysis
od: M. V. Timerbulatov, et al.
Izdano: (2021-10-01)

Intraocular pressure during haemodialysis
od: Sud R, et al.
Izdano: (1988-01-01)

Use of Intramuscular Ephedrine Sulfate During Kidney Transplantation
od: Patel GP, et al.
Izdano: (2023-06-01)

ANCA Associated Vasculitis Subtypes: Response [Response to Letter]
od: Austin K, et al.
Izdano: (2022-10-01)

ANCA Associated Vasculitis Subtypes: Recent Insights and Future Perspectives
od: Austin K, et al.
Izdano: (2022-04-01)

A field effect spacecraft neutraliser for fundamental physics missions
od: Kent, B, et al.
Izdano: (2004)

Haemodialysis cataract
od: Angra S, et al.
Izdano: (1987-01-01)

Lack of seroresponse to SARS-CoV-2 booster vaccines given early post-transplant in patients primed pre-transplantation
od: Sarah Gleeson, et al.
Izdano: (2023-01-01)

Neutralising antibodies for Mayaro virus in Pantanal, Brazil
od: Alex Pauvolid-Corrêa, et al.
Izdano: (2015-02-01)

Non-Linear Control of a Neutralisation Process
od: P D Roberts PhD, BEng, CEng, MIEE
Izdano: (1971-09-01)

Schmallenberg virus neutralising antibody responses in sheep
od: Scott Jones, et al.
Izdano: (2019-11-01)

Identification of neutralising pembrolizumab anti-drug antibodies in patients with melanoma
od: S. C. Sasson, et al.
Izdano: (2021-09-01)

Efficacy of sub-Tenon's block using an equal volume of local anaesthetic administered either as a single or as divided doses. A randomised clinical trial
od: McAdoo John, et al.
Izdano: (2009-03-01)

Glycan masking of a non-neutralising epitope enhances neutralising antibodies targeting the RBD of SARS-CoV-2 and its variants
od: George W. Carnell, et al.
Izdano: (2023-02-01)